Safety, Tolerability, and Effectiveness of Rasagiline Mesylate in Patients With Parkinson's Disease
- Study Title
- Safety, Tolerability, and Effectiveness of Rasagiline Mesylate in Patients With Parkinson's Disease
- Teva Identifier
- TVP - 1012/233
- ClinicalTrials.gov Identifier
- NCT00203138
- Study Status
- Completed
- Trial Condition(s)
- Parkinson's Disease
- Interventions
- Drug: rasagiline mesylate
Study Description
Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult, Older Adult
- Age Range
- 35 Years and older
- Trial Duration
- 06/01/2004 - 12/01/2006
- Phase
- Phase 3
